Director/PDMR Shareholding
CVS Group plc announced that Paul Higgs, Director and Chief Veterinary Officer, purchased 1,235 ordinary shares for 1,213.996 pence each, increasing his total holding to 4,931 shares representing 0.007 per cent of voting rights. Additionally, Joanne Shaw, Non-Executive Director, purchased 825 ordinary shares for 1,210.679 pence each, bringing her total interest to 2,387 shares, or 0.003 per cent of voting rights. These on-market purchases occurred on 5 December 2025 on the London Stock Exchange's AIM market.
Select text to share a quote on X · sign in to keep highlights & notes in your CVSG notes
CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 5th & 8th December 2025 respectively of the following share purchases:
- Paul Higgs, Director and Chief Veterinary Officer of the Company purchased 1,235 Ordinary Shares. As a result Paul Higgs's total interest in the Company is now 4,931 Ordinary shares, representing 0.007 per cent of the total voting rights of the Company.
- Joanne Shaw, Non-Executive Director of the Company purchased 825 Ordinary Shares. As a result Joanne Shaw's total interest in the Company is now 2,387 Ordinary shares, representing 0.003 per cent of the total voting rights of the Company.
The notifications below, made in accordance with the requirements of UK MAR, provide further detail.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Paul Higgs | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR (Director and Chief Veterinary Officer) | ||||
| b) | Initial notification /Amendment | Initial Notification | ||||
| a) | Name | CVS Group plc | ||||
| b) | LEI | 213800J41XDQ2NX48O05 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 0.2 pence each GB00B2863827 | ||||
| b) | Nature of the transaction | On-market purchase | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 5 December 2025 | ||||
| f) | Place of the transaction | London Stock Exchange - AIM (XLON) | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Joanne Shaw | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR (Non-Executive Director) | ||||
| b) | Initial notification /Amendment | Initial Notification | ||||
| a) | Name | CVS Group plc | ||||
| b) | LEI | 213800J41XDQ2NX48O05 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 0.2 pence each GB00B2863827 | ||||
| b) | Nature of the transaction | On-market purchase | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 5 December 2025 | ||||
| f) | Place of the transaction | London Stock Exchange - AIM (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.